Display options
Share it on

Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux, Richard C Mohs, John C Morris, Martin N Rossor, Philip Scheltens, Maria C Carrillo, Bill Thies, Sandra Weintraub, Creighton H Phelps

Affiliations

  1. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. [email protected]

PMID: 21514250 PMCID: PMC3312024 DOI: 10.1016/j.jalz.2011.03.005

Abstract

The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia. The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available. We present criteria for all-cause dementia and for AD dementia. We retained the general framework of probable AD dementia from the 1984 criteria. On the basis of the past 27 years of experience, we made several changes in the clinical criteria for the diagnosis. We also retained the term possible AD dementia, but redefined it in a manner more focused than before. Biomarker evidence was also integrated into the diagnostic formulations for probable and possible AD dementia for use in research settings. The core clinical criteria for AD dementia will continue to be the cornerstone of the diagnosis in clinical practice, but biomarker evidence is expected to enhance the pathophysiological specificity of the diagnosis of AD dementia. Much work lies ahead for validating the biomarker diagnosis of AD dementia.

Copyright © 2011. Published by Elsevier Inc.

References

  1. Ann Neurol. 2008 Oct;64(4):388-401 - PubMed
  2. Neurology. 1998 Dec;51(6):1546-54 - PubMed
  3. Neurology. 1993 Feb;43(2):250-60 - PubMed
  4. Neurology. 2011 Mar 15;76(11):1006-14 - PubMed
  5. Neurology. 2001 May 8;56(9):1143-53 - PubMed
  6. Am J Geriatr Psychiatry. 2004 Mar-Apr;12(2):146-56 - PubMed
  7. Neurology. 2005 Dec 27;65(12):1863-72 - PubMed
  8. Ann Neurol. 2009 Feb;65(2):176-83 - PubMed
  9. Lancet Neurol. 2010 Jan;9(1):119-28 - PubMed
  10. Alzheimer Dis Assoc Disord. 2007 Oct-Dec;21(4):S14-8 - PubMed
  11. Alzheimers Dement. 2011 May;7(3):280-92 - PubMed
  12. Alzheimers Dement. 2008 Jan;4(1):38-48 - PubMed
  13. J Neuropathol Exp Neurol. 1997 Oct;56(10):1095-7 - PubMed
  14. N Engl J Med. 1998 Feb 19;338(8):506-11 - PubMed
  15. Alzheimers Dement. 2011 May;7(3):270-9 - PubMed
  16. Lancet Neurol. 2007 Aug;6(8):734-46 - PubMed
  17. Brain. 2007 Oct;130(Pt 10):2636-45 - PubMed
  18. Brain. 2008 Mar;131(Pt 3):665-80 - PubMed
  19. Alzheimers Dement. 2011 May;7(3):257-62 - PubMed
  20. Ann Neurol. 2010 Mar;67(3):317-24 - PubMed
  21. Arch Neurol. 2001 Nov;58(11):1803-9 - PubMed
  22. Brain. 2010 Aug;133(Pt 8):2225-31 - PubMed
  23. Nat Rev Neurosci. 2008 Oct;9(10):768-78 - PubMed
  24. Neurology. 1984 Jul;34(7):939-44 - PubMed

Substances

MeSH terms

Publication Types

Grant support